Sengupta Shomik, Cheville John C, Lohse Christine M, Zincke Horst, Myers Robert P, Riehle Darren L, Pankratz V Shane, Blute Michael L, Sebo Thomas J
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Urology. 2006 Jul;68(1):94-8. doi: 10.1016/j.urology.2006.01.068.
The preoperative prediction of the likelihood of positive surgical margins (+SMs) at radical retropubic prostatectomy (RRP) may be useful for counseling and determining the surgical approach. The aim of this study was to assess the additional value of digital image analysis (DIA) of ploidy and proliferation on needle biopsies, in addition to the known preoperative predictors of +SMs at RRP.
We identified 454 patients treated by RRP at our institution from 1995 to 1998 for prostate cancer verified by transrectal ultrasound-guided biopsy, with a specimen adequate for DIA. Patients receiving preoperative hormonal therapy were excluded. The clinical features, transrectal ultrasound-guided biopsy findings, and DIA evaluation of MIB-I immunostaining and DNA ploidy were assessed in a multivariate logistic regression model to predict for +SMs at RRP.
The mean +/- SD age at treatment was 64.5 +/- 6.5 years, the percentage of positive cores was 40.4% +/- 24.3%, the median prostate-specific antigen level was 6.3 ng/mL (range 0.6 to 112.0), median biopsy Gleason score was 6 (range 4 to 9), and median percentage of diploid nuclei was 67% (range 0% to 100%). Of the 454 patients, 185 (40.7%) had +SMs; this finding was time dependent (1995 to 1996, 45% and 1997 to 1998, 31%; P = 0.004). Univariately, preoperative prostate-specific antigen, biopsy Gleason score, extent of cancer on biopsy, MIB-1 expression, percentage of diploid or nondiploid nuclei, and year of surgery were predictive for +SMs. On multivariate analysis, the preoperative prostate-specific antigen level, biopsy Gleason score, percentage of positive cores, and year of surgery remained significant.
The results of our study have shown that the likelihood of +SMs at RRP is best predicted on the basis of conventional prognostic factors. The DIA features of needle biopsies did not provide additional predictive power.
在耻骨后根治性前列腺切除术(RRP)中,术前预测手术切缘阳性(+SMs)的可能性对于患者咨询和确定手术方式可能有用。本研究的目的是评估除RRP中已知的术前+SMs预测因素外,针吸活检中倍体和增殖的数字图像分析(DIA)的附加价值。
我们确定了1995年至1998年在我院接受RRP治疗的454例前列腺癌患者,这些患者经直肠超声引导下活检确诊,且有足够的标本用于DIA。排除接受术前激素治疗的患者。在多变量逻辑回归模型中评估临床特征、经直肠超声引导下活检结果以及MIB-I免疫染色和DNA倍体的DIA评估,以预测RRP中的+SMs。
治疗时的平均年龄±标准差为64.5±6.5岁,阳性核心的百分比为40.4%±24.3%,前列腺特异性抗原水平中位数为6.3 ng/mL(范围0.6至112.0),活检Gleason评分中位数为6(范围4至9),二倍体核百分比中位数为67%(范围0%至100%)。在454例患者中,185例(40.7%)有+SMs;这一发现与时间有关(1995年至1996年为45%,1997年至1998年为31%;P = 0.004)。单因素分析显示,术前前列腺特异性抗原、活检Gleason评分、活检时癌症范围、MIB-1表达、二倍体或非二倍体核百分比以及手术年份可预测+SMs。多变量分析显示,术前前列腺特异性抗原水平、活检Gleason评分、阳性核心百分比和手术年份仍然具有显著性。
我们的研究结果表明,基于传统预后因素能最好地预测RRP中+SMs的可能性。针吸活检的DIA特征未提供额外的预测能力。